X
skip to main content
Logo
media conference

Press Releases

  • May 17, 2018

    A new study by Dr. Rebecca Auer, a member of TFRI's Oncolytical Virus project and a former recipient of the TFRI New Investigator Award, suggests that a common treatment for erectile dysfunction combined with the flu vaccine may be able to help the immune system mop up cancer cells left behind after surgery. The study, published in OncoImmunology, shows that this unconventional strategy can reduce the spread of cancer by more than 90 percent in a mouse model. It is now being evaluated in a world-first clinical trial.

  • May 10, 2018

    A new study led by a team of TFRI-funded researchers has uncovered the mechanisms through which deadly ovarian cancer cells escape the immune system, setting the stage for a better understanding of how and why patients respond to promising new immunotherapies.

  • April 25, 2018

    TFRI's Atlantic node and the Beatrice Hunter Cancer Research Institute will hold a joint workshop on May 25 for researchers and students in Atlantic Canada on the subject of "The Many Ways to Science." All details for the meeting can be found at https://www.fourwav.es/view/672/info/ .

  • April 06, 2018

    “If we could determine up front which patients were higher risk we might be able to adapt our treatment, and hopefully improve outcomes for patients,” says TFRI New Investigator Dr. Robert Kridel, a clinician-scientist at Princess Margaret Cancer Centre who is studying follicular lymphoma with his new $450,000 award .

  • March 07, 2018

    Brain cancer research in Manitoba has received a boost with news that a local scientist has won a prestigious cancer research award from the Terry Fox Research Institute. Dr. Sachin Katyal, a biologist at CancerCare Manitoba and the University of Manitoba, is the first researcher in Manitoba to receive the $450,000 Terry Fox New Investigator award for his “quick-to-clinic” personalized medicine approach to better treat patients with glioblastoma multiforme (GBM).

  • March 06, 2018

    Canadian pancreatic cancer researchers are joining forces under a Terry Fox initiative bringing new hope for patients with this deadly disease.

  • February 15, 2018

    A Vancouver team led by TFRI-funded investigator Dr. David Huntsman has discovered an important therapeutic target for treating small cell carcinoma of the ovary, hypercalcemic type (SCCOHT). This is a rare, but extremely lethal, ovarian cancer in young women with no effective treatment.

  • February 15, 2018

    A pan-Canadian TFRI team of cancer researchers has developed a predictive model for detecting early-stage lung cancer in high-risk individuals with significantly greater accuracy than other leading models. This study suggests the team’s innovative approach could be considered for use in lung cancer screening programs both in Canada and around the world.

  • February 15, 2018

    A recent study by TFRI’s cancer metabolism group suggests nuclear mTOR (a kinase) also works as a transcriptional regulator of metabolism in the proliferation of prostate cancer.

  • February 15, 2018

    A new class of compounds is generating excitement for its ability to enhance the efficacy of oncolytic viruses (OVs) and to stimulate the immune response against tumours when used in combination therapy.

  • February 15, 2018

    What if there was a way to make cancer cells more susceptible to radiation therapy without damaging healthy cells? New findings from Toronto researchers have shown ultrasound- stimulated microbubbles is a novel type of treatment that may achieve just that.

  • February 15, 2018

    While nuclear mutations are widely acknowledged as a driver of cancer tumours, the role of maternally inherited mitochondrial genome mutations has not been extensively explored – but now a paper from a prolific TFRI-funded team has suggested an important interplay between the two mutations when it comes to prostate cancer tumours.

  • January 19, 2018

    The annual Terry Fox Research Institute’s Ontario Node Research Symposium took place Monday, Dec. 4, 2017 at the MaRS Discovery Centre in Toronto. Photos of the event are now posted, check out the gallery here.

  • December 12, 2017

    More than 200 cancer researchers attended TFRI's 8th Annual Scientific Meeting in Vancouver on Nov. 4. Photos of the event are now posted, check out the gallery here.

  • December 07, 2017

    This was a big year for the Terry Fox Research Institute: 2017 marked our 10th anniversary. Here are two videos we created to celebrate this milestone, telling the story of TFRI's origins, and how we are achieving Terry Fox's dream of finding cures for cancer through research.

Back to Top